Skip to main content

Table 5 Predicted and actual risk of COVID-19 deterioration in the validation cohort according to each (a) DOATS score and (b) DOAT score

From: Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19

(a)

(b)

DOATS score

No.

Predicted (%)

Actual (%)

DOAT score

No.

Predicted (%)

Actual (%)

-2

2

0.8

0

-2

4

0.9

0

-1

4

1

0

-1

7

1.2

0

0

13

1.3

0

0

24

1.7

0

1

16

1.7

0

1

52

2.5

5.8

2

17

2.2

11.8

2

14

3.5

0

3

32

2.9

0

3

19

5

0

4

25

3.7

4

4

41

6.9

4.9

5

15

4.8

6.7

5

52

9.6

15.4

6

30

6.2

6.7

6

20

13.3

20

7

18

8

0

7

10

18

20

8

17

10.2

5.9

8

32

23.9

25

9

40

12.9

17.5

9

32

31

34.4

10

6

16.2

33.3

11

8

47.9

25

11

22

20.2

40.9

12

5

56.9

20

12

16

24.9

25

    

13

7

30.2

14.3

    

14

17

36.2

35.3

    

15

9

42.6

22.2

    

16

5

49.2

20

    

17

3

55.9

33.3

    

18

1

62.3

0

    
  1. Coronavirus disease 2019, COVID-19; comorbidities of diabetes/obesity, age, body temperature, and oxygen saturation, DOATS; comorbidities of diabetes/obesity, age, and body temperature, DOAT